HOME >> BIOLOGY >> NEWS
Bacterial response to oxidation studied as toxin barometer

is focused on neuroscience, particularly brain injury and aging, and nanotechnology (http://nanoneuro.vcom.vt.edu/).

It is a good sensor because it measures biological effect rather than concentrations, Rzigalinski said. So we can measure oxidative damage when we stick the sensor in the water, not individual concentrations of individual chemicals. It also announces the presence of an oxidative toxin you havent identified.

We dont have to have 20 sensors for 20 toxins. We can sense the presence of any oxidative toxin, Love said.

Ikuma, who was an undergraduate biology student at Virginia Tech when she began working with Love, has now come full circle from a biology student working on a civil engineering research project to an engineering student working on a biology project. She will deliver the paper, Predicting the public health impact of oxidative toxins using a bacterial glutathione-gated potassium efflux stress response biosensor (GEOC 51) at 3:25 p.m., Monday, March 26, in McCormick Place North room N427A. Rzigalinski and Nancy Love are the co-authors.


'"/>

Contact: Susan Trulove
STrulove@vt.edu
540-231-5646
Virginia Tech
26-Mar-2007


Page: 1 2 3

Related biology news :

1. Better together: Bacterial endosymbionts are essential for the reproduction of a fungus
2. Bacterial walls come tumbling down
3. Bacterial switch gene regulates how oceans emit sulfur into atmosphere
4. Bacterial protein shows promise in treating intestinal parasites
5. The results are in: Bacterial parasite strives for balance in host infection
6. Bacterial protein mimics host to cripple defenses
7. Say what? Bacterial conversation stoppers
8. Bacterial cooperation as a target for anti-infectious therapy
9. New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids
10. Bacterial spread all down to chance: Some strains just the lucky ones
11. OHSU study: Bacterial switching mechanism key to survival

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bacterial response oxidation studied toxin barometer

(Date:5/22/2015)... OXFORD, CT , May 22, 2015  NXT-ID, Inc. ... from June 1st, it will be ending its promotional pricing ... www.wocketwallet.com . Laurence Savin , Head of ... our exclusive promotional pricing until the end of May. To ... at wocketwallet.com/invite and when we open the store on June ...
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
(Date:5/26/2015)... May 26, 2015 Tianyin Pharmaceutical Inc. (NYSE ... in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... the Company,s Annual Meeting of Shareholders for fiscal year ... held at the Company,s office located in ... 9:00 AM (local time in Chengdu, China ...
(Date:5/26/2015)... 26, 2015 Pharmaco-Kinesis Corporation (PKC) announced today ... at Shutters on the Beach in Santa ... of the Company,s innovative Metronomic Biofeedback Pump (MBP), a ... chemotherapy over time to a target site of the ... biofeedback system in real-time.  ...
(Date:5/26/2015)... May 26, 2015 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral ... the study protocol for the company,s Phase IIb trial ... Food and Drug Administration (FDA). The submission was made ... The Phase IIb study of ORMD-0801 for ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Just the ... a long-standing unmet biomedical need does not guarantee immediate ... problem that has seen many prior failures is often ... acceptance and use is an irony that is often ... small, new start-up company, Asymmetrex has found ...
Breaking Biology Technology:TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 2Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 4Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 2In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 3
Cached News: